戻る Agenda
Session 7, Track C: Patient Centricity as a Key Component for Successful Pharmacovigilance Strategies (Part II)
Session Chair(s)
Raphael Elmadjian Pareschi, PharmD, MBA
Patient Safety Lead/ Head of Pharmacovigilance Brazil
Roche, Brazil
Bianca Passos, MBA, RPh
Country Safety Head - Brazil
Sanofi, Brazil
This session is part two of our previous session providing a comprehensive overview of the importance of involving the patient to gather insights and sharp decision-making to enable the safe use of medicines. Attendees will gain insights from industry and regulators on this topic to highlight the importance of putting the patient at the center of what we do throughout the product’s lifecycle in relation to effective risk mitigation.
Learning Objective : - Recognize the importance of input from patients for effective decision-making strategies for pharmacovigilance
- Discuss effective strategies for risk communication, how to combat misinformation to enable stakeholders to make informed decisions and improve their experience with the use of medicinal products
- Describe successful patient centric initiatives in risk communication
Speaker(s)
Gravitate-Health: Empowering Patients with Health Information
Alan Hochberg
Genentech, A Member of the Roche Group, United States
Principal Scientific Enablement Director, Scientific Enablement and Processes
Speaker
Kristof Vanfraechem, MSc
Data for Patients, Belgium
Founder and CEO
Speaker
Christine Von Raesfeld
The Light Collective, United States
Founder/SME, Patient Experience
Speaker
Carolina Consuegra, MBA
Science to People, Colombia
Co-Founder